Comprehensive Clinical and Pathological Analysis of Chronic Arsenic Poisoning

Overview and Pathological Indicators of Arsenic Toxicity

Chronic arsenic poisoning, or arsenicosis, results in extensive systemic damage detectable through clinical symptoms and post-mortem examination. Early pathological findings may include a pale-violet appearance of the mucus or submucous tissues. Organs are frequently found to be enlarged, and the adrenal cortices typically exhibit fatty or hemorrhagic changes. In terms of dosage, concentrations of 200−300 mg200-300\,mg are significant in the context of toxicity, though levels may vary in individuals known as arsenophagists who regularly consume the substance. Chronic poisoning is often diagnostically indicated by a persistent metallic taste, excessive salivation, and a characteristic garlic-like odor observed in both the breath and the sweat.

Dermatological and Ungual Manifestations

The skin and nails provide critical diagnostic evidence of chronic exposure. One of the earliest signs of arsenicosis is the development of melanosis and leucomelanosis, which may occur with or without concurrent keratosis. Patients may develop a rash that resembles a fading measles rash. A hallmark condition is "raindrop pigmentation," characterized by speckled brown pigmentation appearing primarily on the skin flexures, temples, shoulders, eyelids, and neck. Additionally, leucomelanosis manifests as macular areas of depigmentation on either normal or hyperpigmented skin. Hyperkeratosis, an irregular thickening of the skin, is commonly seen on the palms and soles. The nails are equally affected, often becoming brittle and developing white bands of opacity known as Aldrich-Mees lines. Alopecia, or hair loss, is another frequent dermatological complication.

Gastrointestinal and Ocular Symptoms

Chronic ingestion of arsenic leads to significant gastrointestinal tract (GIT) distress. Symptoms include persistent nausea, vomiting, abdominal cramps, and a loss of appetite. Patients may suffer from alternating constipation or diarrhea, as well as excessive salivation. Ocular involvement is marked by congestion and constant watering of the eyes, often accompanied by photophobia, an abnormal sensitivity to light.

Respiratory and Cardiovascular Complications

The respiratory system (RS) suffers from chronic irritation, leading to a persistent cough, hoarseness of voice, and bronchial catarrh. In advanced cases, hemoptysis (the coughing up of blood) and dyspnea (shortness of breath) may develop. The cardiovascular system (CVS) is similarly impacted, with long-term exposure leading to hypertension, ischemic heart disease, and cardiac failure. Dependent edema, which is swelling in the lower extremities, is a common physical finding related to these cardiovascular impairments.

Neurological and Renal Pathology

Chronic arsenic toxicity leads to severe neurological degradation. Peripheral neuropathy typically begins with tingling and numbness in the hands and feet. This can progress to polyneuritis, anesthesia, and paresthesia, sometimes accompanied by painful swelling known as erythromelalgia. This neuritis often resembles the patterns seen in chronic alcoholism, and encephalopathy may also occur. Renal involvement is characterized by chronic nephritis. A unique diagnostic feature is that the urine may change color to red or green. Patients may experience dysuria (painful urination) and anuria (failure of the kidneys to produce urine) arising from renal tubular necrosis.

Hepatic, Hematologic, and Long-Term Sequelae

The liver and blood-forming systems are profoundly affected by chronic exposure. Hepatic signs include hepatomegaly, jaundice, and the eventual development of cirrhosis. Hematologic complications include bone marrow suppression, hypoplasia, anemia, and thrombocytopenia. There is also a notable link between chronic arsenic exposure and the development of leukemia. Long-term survivors of chronic poisoning may develop secondary conditions such as diabetes, vasospasm, and peripheral vascular insufficiency. A specific manifestation of this vascular damage is "blackfoot disease," which involves severe circulatory compromise in the extremities.